A Double‐blind, Randomized, Placebo‐controlled, Phase II Trial of Baricitinib for Systemic Lupus Erythematosus: How to Optimize Lupus Trials to Examine Effects on Cutaneous Lupus Erythematosus

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.17344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cutaneous Manifestations of Systemic Lupus Erythematosus

International Journal of Research in Dermatology
2018English

Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Systemic Lupus Erythematosus

JAMA - Journal of the American Medical Association
Medicine
2011English

Systemic Lupus Erythematosus

Deutsche Medizinische Wochenschrift
Medicine
2005English

Systemic Lupus Erythematosus

Clinical and Developmental Immunology
2012English

Systemic Lupus Erythematosus

Journal of the American Dental Association
MedicineDentistry
1980English

Systemic Lupus Erythematosus

Rheumatology
RheumatologyPharmacology
1994English

559 Higher Skin Disease Scores Distinguish Patients Who Progress From Cutaneous Lupus Erythematosus to Systemic Lupus Erythematosus

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Subacute Cutaneous Lupus Erythematosus

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy